Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
The additional funding raised through this round will allow Hexarad to continue to grow its radiology platform which focuses on allocative efficiency to improve scan reporting times.
Urolithiasis is a common disease affecting about 12% of the global population. Consequently, urolithiasis is a widespread disease with significant socioeconomic impact and is relevant to healthcare in terms of society and health policy.
American Injectables is now well positioned to help fill the gap in US-based manufacturing of sterile injectables to alleviate current drug shortages.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm ET
Florida / New York
Phone: 561.316.3330